1IA
EW icon

1834 Investment Advisors’s Edwards Lifesciences EW Stock Holding History

1834 Investment Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,652
Closed -$833K – 205
2025
Q2 		$833K Buy
10,652
+545
+5% +$40.6K 0.11% 126
2025
Q1 		$733K Buy
10,107
+1,429
+16% +$102K 0.09% 136
2024
Q4 		$642K Sell
8,678
-540
-6% -$37.8K 0.08% 139
2024
Q3 		$608K Buy
9,218
+715
+8% +$51.9K 0.07% 147
2024
Q2 		$785K Buy
8,503
+747
+10% +$66.2K 0.09% 135
2024
Q1 		$741K Buy
7,756
+482
+7% +$40.5K 0.09% 138
2023
Q4 		$555K Sell
7,274
-1,811
-20% -$126K 0.07% 161
2023
Q3 		$629K Buy
9,085
+850
+10% +$68.3K 0.08% 151
2023
Q2 		$777K Sell
8,235
-426
-5% -$37K 0.09% 143
2023
Q1 		$717K Buy
+8,661
New +$681K 0.09% 141
2021
Q1 		– Sell
-16
Closed -$1K – 471
2020
Q4 		$1K Buy
+16
New +$1.33K ﹤0.01% 447

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

1834 Investment Advisors's EW Position: Q3 2025 in Review

1834 Investment Advisors sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 10,652 shares — an estimated $833K sold.

1834 Investment Advisors first reported a position in EW in Q4 2020 and held it in 11 quarters. The position peaked at $833K in Q2 2025. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • 1834 Investment Advisors reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • 1834 Investment Advisors sold 10,652 Edwards Lifesciences shares in Q3 2025, an estimated $833K.
  • 1834 Investment Advisors first reported a position in Edwards Lifesciences in Q4 2020 and held it in 11 quarters.
  • 1834 Investment Advisors's Edwards Lifesciences position peaked at $833K in Q2 2025.
  • 1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on 1834 Investment Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.